Understanding the risk of emerging bacterial resistance to over the counter antibiotics in topical sore throat medicines.
R WesgateC EvangelistaR AtkinsonA ShepardO AdegokeJean-Yves MaillardPublished in: Journal of applied microbiology (2020)
Tackling antibiotic resistance is a high worldwide priority. It is widely accepted that the overuse and misuse of antibiotics increase the risk of the development and spread of antibiotic resistance within communities. A number of OTC sore throat products, widely available across the world for topical use in respiratory indications, contain locally delivered antibiotics. Our findings showed that these antibiotics in OTC medicines present a risk for emerging cross-resistance in a number of bacterial respiratory pathogens.